Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

Table 1.

Clinicopathologic characteristics of all patients.

More »

Table 1 Expand

Fig 1.

Representative case of positive DWI rim sign.

Diffusion weighted image (b = 750 s/mm2) shows a complete high signal rim surrounding the right breast mass.

More »

Fig 1 Expand

Fig 2.

A 41-year-old woman with triple-negative cancer in the right breast (poorly differentiated grade, high Ki-67 index, and high ADC kurtosis).

Fat-suppressed contrast-enhanced T1-weighted imaging (a) shows an irregular rim-enhancing mass (arrow). A DWI (b = 750 s/mm2) (b) shows positive rim sign (arrow). DWI slice of tumor volume reconstruction of ADC values (c) and a histogram map (d) are shown. ADC mean; mode; and 25th, 50th, and 75th percentiles were 1.099, 0.745, 0.859, 1.075, and 1.245 x 10−3 mm2/s, respectively. The ADC skewness and kurtosis were 1.59 and 4.28, respectively. The 3-cm-sized tumor had a poor histologic grade and high Ki-67 index (50%).

More »

Fig 2 Expand

Fig 3.

A 45-year-old woman with ER-positive cancer in the right breast (well differentiated grade, low Ki-67 index, and low ADC kurtosis).

Fat-suppressed contrast-enhanced T1-weighted imaging (a) shows an irregular heterogeneously enhancing mass (arrowhead). An ADC map (b) shows positive rim sign (arrow). DWI with tumor volume reconstruction of ADC values (c) and a histogram map (d) are shown. ADC mean; mode; and 25th, 50th, and 75th percentiles were 0.653, 0.389, 0.414, 0.603, and 0.908 x 10−3 mm2/s, respectively. The ADC skewness and kurtosis were 0.14 and -1.39, respectively. The 2-cm-sized tumor had a well-moderate histologic grade and low Ki-67 index (10%).

More »

Fig 3 Expand

Table 2.

Clinicopathologic associations between triple-negative and ER-positive breast cancers.

More »

Table 2 Expand

Table 3.

Associations of MRI features between triple-negative and ER-positive breast cancers.

More »

Table 3 Expand